{"_self":{"principle":"Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.","widget":"article_topology","feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","contains":"claims, sources, anecdotes, question_graph slice","slug":"ss-31-nsaids","urls":{"read":"https://miscsubjects.com/api/articles/ss-31-nsaids/topology"},"how_to_use":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","write":null,"imessage":null,"router_tag":null,"proof_chain":[{"step":1,"claim":"Articles are voxel graphs of tiered claims, not prose blobs.","verify":"https://miscsubjects.com/api/articles/constitution"},{"step":2,"claim":"Claims link to hash-chained sources via source_ids.","verify":"https://miscsubjects.com/api/articles/ss-31-nsaids/sources"},{"step":3,"claim":"Ask reads topology; ingest/claim append to ledger.","verify":"https://miscsubjects.com/api/protocol"},{"step":4,"claim":"Models queue growth: populate → collaborate → repair → reflex.","verify":"https://miscsubjects.com/api/protocol/grow"},{"step":5,"claim":"Graph proves its own shape (reflex) and $/claim (yield).","verify":"https://miscsubjects.com/graph.html?layer=reflex"},{"step":6,"claim":"Full feature index + _explain on every API response.","verify":"https://miscsubjects.com/api/articles/system-map"}],"related_features":[{"id":"ask","name":"Ask protocol","what":"Answer only from topology; creates question_node with gaps and ingest_hint.","urls":{"read":"https://miscsubjects.com/api/articles/ss-31-nsaids/prompts","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"graph_topology","name":"Cross-article graph","what":"Merged claims/sources across condition+stack slugs for one question.","urls":{"read":"https://miscsubjects.com/api/articles/ss-31-nsaids/graph-topology?question=..."}},{"id":"question_graph","name":"Question graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output).","urls":{"read":"https://miscsubjects.com/api/articles/ss-31-nsaids/question-graph","write":"https://miscsubjects.com/api/protocol/ask"}},{"id":"voxels","name":"Voxel graph","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance.","urls":{"read":"https://miscsubjects.com/api/articles/ss-31-nsaids/voxels","write":"https://miscsubjects.com/api/protocol/claim"}}],"system_map":"https://miscsubjects.com/api/articles/system-map","system_map_markdown":"https://miscsubjects.com/api/articles/system-map?format=markdown","not_medical_advice":true},"_explain":{"feature":"topology","name":"Article topology","what":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","why":"Every feature is auditable collective intelligence","how":"Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER.","model":null,"verifies":null,"urls":{"read":"https://miscsubjects.com/api/articles/ss-31-nsaids/topology"},"imessage":null,"router":null,"related":[{"id":"ask","what":"Answer only from topology; creates question_node with gaps and ingest_hint."},{"id":"graph_topology","what":"Merged claims/sources across condition+stack slugs for one question."},{"id":"question_graph","what":"Ask nodes (questions + gaps) and evidence_ingest nodes (pasted model output)."},{"id":"voxels","what":"Claims as atoms, sources as edges (supported_by, posted_by). Per-claim provenance."}],"not_medical_advice":true},"slug":"ss-31-nsaids","title":"SS-31 for NSAIDs: Mitochondrial Repair vs Symptom Suppression","register":"source_ledger","tags":["peptide","matrix"],"updated_at":"2026-07-17T02:42:06.643Z","body_excerpt":"## What's breaking down if you have NSAIDs\n\nNSAIDs reduce pain and swelling by blocking COX enzymes and lowering prostaglandin signals. This suppresses the inflammatory response but can slow the natural repair processes that follow tissue stress. Chronic use has been linked in preclinical work to mitochondrial stress in kidney and gut cells through oxidative load and altered energy handling. If your NSAID use contributes to ongoing cellular fatigue or slower recovery in those tissues, the core issue sits at the mitochondrial level where energy production and ROS management decline faster than repair mechanisms restore them.\n\n## Why SS-31 (Elamipretide) might help you\n\n1. You are reading about **NSAIDs** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain.\n\nSS-31 binds cardiolipin in the inner mitochondrial membrane. This stabilizes cristae structure and supports electron transport chain efficiency. If NSAID-related oxidative stress has impaired mitochondrial ATP output in your cells, SS-31 is studied for restoring membrane potential and reducing electron leak. Preclinical rodent models of LPS-induced inflammation show improved hippocampal mitochondrial function and ATP levels after SS-31 (preclinical). Human data on direct NSAID cross remain absent, so any link stays mechanistic.\n\n## Why NSAIDs matters for you\n\n**Drug:** NSAIDs\n**What it does:** Suppress inflammation signal; may slow structural repair cascade.\n**Therefore for you:** NSAIDs suppress a signal. This reduces immediate mechanical load from swelling and pain in some users but trades off against full repair cascades that require controlled inflammation. Mitochondrial support compounds like SS-31 sit on the repair side of that balance.\n\n## How these fit together\n\nSingle-compound focus — SS-31 (Elamipretide) targets the mitochondrial layer. NSAIDs handle symptom load. The two operate on separate degeneration layers: one damps the signal, the other supports the organelle machinery that generates energy for repair.\n\n## What the evidence actually shows\n\nHuman trials of SS-31 exist for Barth syndrome (FDA approval 2025 based on TAZPOWER open-label extension showing muscle strength gains, human), primary mitochondrial myopathy (mixed Phase 3 results, human), and heart failure (negative primary endpoints in some trials, human). No published human trials test SS-31 against NSAID-induced changes. Preclinical rodent studies demonstrate mitochondrial protection in inflammation models (Zhao 2019, preclinical). In vitro work shows cardiolipin stabilization and reduced ROS (mechanistic). One clinical note cautions against combining SS-31 with chronic NSAIDs due to renal clearance overlap (anecdotal/clinical guidance).\n\n## What scientists say\n\nResearchers describe SS-31 as a cardiolipin-targeting peptide that improves bioenergetics in aged or stressed mitochondria without direct anti-inflammatory signaling (review, mechanistic). Clinical trial authors note benefits appear clearest in primary mitochondrial disorders rather than secondary insults like drug effects.\n\n## What people say on Reddit\n\nUsers discuss SS-31 for general mitochondrial support and energy, often alongside other peptides. No threads specifically link it to NSAID recovery or reversal of NSAID side effects. Anecdotes remain broad (anecdotal).\n\n## What people say on X\n\nNo relevant posts found matching SS-31 and NSAIDs together.\n\n## What we do not know\n\nWhether SS-31 meaningfully offsets any mitochondrial effects of NSAIDs in humans. Long-term stacking data with NSAIDs. Optimal timing or sequencing relative to NSAID use.\n\n## Safety and limits\n\nSS-31 has shown mild adverse events in trials (human). Kidney clearance means caution with nephrotoxic drugs including NSAIDs is noted in some provider materials. All use remains investigational outside approved indicat","ranking":"safety-first (interaction_risk/limitations), then quote-gated effective_weight","claims":[{"id":"c7","text":"Provider materials note caution combining SS-31 with chronic NSAIDs due to renal clearance.","tier":"anecdotal","weight":0.3,"section":"Safety and limits","slot":"limitations","interaction_risk":false,"status":"active","source_ids":["s10"],"source_status":"sourced","why_material":"Practical safety note tied to the drug cross.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c6","text":"No published human trials on SS-31 and NSAID cross.","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":[],"source_status":"unsourced","why_material":"Clarifies evidence gap for this specific pairing.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.8,"quote_gated":false},{"id":"c2","text":"Chronic NSAID use linked to mitochondrial stress in kidney/gut cells in preclinical models.","tier":"preclinical","weight":0.5,"section":"What's breaking down if you have NSAIDs","slot":null,"interaction_risk":false,"status":"active","source_ids":[],"source_status":"unsourced","why_material":"Establishes the mitochondrial layer relevant to SS-31.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c4","text":"Rodent LPS inflammation model showed SS-31 improved mitochondrial function and ATP (preclinical).","tier":"preclinical","weight":0.5,"section":"Why SS-31 (Elamipretide) might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s0"],"source_status":"sourced","why_material":"Closest preclinical inflammation-mito data.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.5,"quote_gated":false},{"id":"c1","text":"NSAIDs suppress inflammation via COX inhibition but may slow structural repair.","tier":"mechanistic","weight":0.3,"section":"Why NSAIDs matters for you","slot":null,"interaction_risk":false,"status":"active","source_ids":[],"source_status":"unsourced","why_material":"Frames the suppression vs repair contrast central to the article.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.3,"quote_gated":false},{"id":"c5","text":"FDA approval of elamipretide for Barth syndrome in 2025 based on TAZPOWER trial muscle strength data (human).","tier":"human","weight":0.8,"section":"What the evidence actually shows","slot":null,"interaction_risk":false,"status":"active","source_ids":["s2"],"source_status":"sourced","why_material":"Highest-tier human evidence for the compound.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true},{"id":"c3","text":"SS-31 binds cardiolipin, stabilizes mitochondrial cristae, and supports ETC efficiency (mechanistic).","tier":"mechanistic","weight":0.3,"section":"Why SS-31 (Elamipretide) might help you","slot":null,"interaction_risk":false,"status":"active","source_ids":["s5","s11"],"source_status":"sourced","why_material":"Core mechanism explaining potential relevance to any mitochondrial stress.","retracted_at":null,"retraction_reason":null,"challenged_by":[],"effective_weight":0.22,"quote_gated":true}],"sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31747905/","title":"Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice","quote":"These findings indicate that LPS-induced memory impairment can be attenuated by the mitochondrion-targeted antioxidant elamipretide.","summary":"Rodent study showing SS-31 protection in LPS inflammation model.","claim_ids":["c4"],"link_status":"ok","quote_status":"verified","hash":"915af4ed997197769acf098b0b09ca70dfdea7e4f30c657437fd453bc0b912df"},{"id":"s2","type":"news","url":"https://www.fightaging.org/archives/2025/10/fda-approval-for-mitochondrial-therapeutic-elamipretide-formerly-ss-31/","title":"FDA Approval for Mitochondrial Therapeutic Elamipretide, Formerly SS-31","quote":"The approval of FORZINITY is supported by the efficacy and safety data from the TAZPOWER clinical trial.","summary":"Reports 2025 FDA approval for Barth syndrome.","claim_ids":["c5"],"link_status":"ok","quote_status":"unverified","hash":"0e1c908ddcd1cdf454bf1ae940632427aa59e396f7723d829b16ef270bcb6f35"},{"id":"s5","type":"other","url":"https://biomeme.com/applications/wellness/peptide-evidence/ss-31/","title":"SS-31 (Elamipretide) — Peptide Evidence Score","quote":"By stabilizing cardiolipin, SS-31 improves mitochondrial bioenergetics, reduces electron leak and ROS production.","summary":"Mechanism summary.","claim_ids":["c3"],"link_status":"ok","quote_status":"unverified","hash":"e6ab73679e02ddcaf58de06ab66c48ff4e0277c5a153fd0d0f2a5c1af88cc0cf"},{"id":"s10","type":"other","url":"https://www.bettermedspa.com/treatments/core-spark-ss-31-elamipretide","title":"Core Spark (SS-31 Elamipretide) Lincoln Park, Chicago","quote":"patients taking nephrotoxic medications (certain antibiotics, chronic NSAID use) should discuss this with their provider before starting.","summary":"Clinical caution note on NSAIDs.","claim_ids":["c7"],"link_status":"ok","quote_status":"verified","hash":"6e706ca2ca670dc5937d2f24df3885e4ccbd1307d6449147506415692a95af9b"},{"id":"s11","type":"pubmed","url":"https://www.mdpi.com/1422-0067/26/3/944","title":"Elamipretide: A Review of Its Structure, Mechanism of Action...","quote":"Consequently, the interaction of Elamipretide with cardiolipin allows for the stabilization of mitochondrial cristae, a reduction in oxidative stress, and the enhancement of ATP production.","summary":"Detailed mechanism review.","claim_ids":["c3"],"link_status":"http_403","quote_status":"unverified","hash":"a345289337289816b68e175c879e32c4a8e79fc4ce294cf8652ce8109491dd9d"}],"anecdotal_sources":[],"scientific_sources":[{"id":"s0","type":"pubmed","url":"https://pubmed.ncbi.nlm.nih.gov/31747905/","title":"Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice","quote":"These findings indicate that LPS-induced memory impairment can be attenuated by the mitochondrion-targeted antioxidant elamipretide.","summary":"Rodent study showing SS-31 protection in LPS inflammation model.","claim_ids":["c4"],"link_status":"ok","quote_status":"verified","hash":"915af4ed997197769acf098b0b09ca70dfdea7e4f30c657437fd453bc0b912df"},{"id":"s11","type":"pubmed","url":"https://www.mdpi.com/1422-0067/26/3/944","title":"Elamipretide: A Review of Its Structure, Mechanism of Action...","quote":"Consequently, the interaction of Elamipretide with cardiolipin allows for the stabilization of mitochondrial cristae, a reduction in oxidative stress, and the enhancement of ATP production.","summary":"Detailed mechanism review.","claim_ids":["c3"],"link_status":"http_403","quote_status":"unverified","hash":"a345289337289816b68e175c879e32c4a8e79fc4ce294cf8652ce8109491dd9d"}],"user_reports":[],"related_articles":[],"question_graph":{"slug":"ss-31-nsaids","questions":[],"evidence":[],"edges":[],"counts":{"questions":0,"evidence":0,"edges":0}},"honesty":{"active_claims":7,"retracted_claims":0,"cut_claims":0,"challenges":0,"scrub_events":0,"note":"Retracted/cut claims stay on ledger but are excluded from ask unless ?include_inactive=1"},"counts":{"claims":7,"claims_total":7,"sources":5,"anecdotal":0,"scientific":2,"user_reports":0,"questions":0,"evidence_ingests":0}}